Intramural teaching and research fellowships comprise the heart of the educational program. However, the center also coordinates didactic and problem-solving educational programs aimed at scientists working in industry and government drug evaluation programs. More information:
The purpose of the center's public policy work is to understand, evaluate, interpret, and define federal government policies that affect the biopharmaceutical industry and in particular the clinical drug development process. Every year the center hosts conferences, workshops, and seminars that are attended by government policy makers, industry representatives, students, and individuals seeking to change careers or simply explore new horizons. These events provide a well-defined and moderated forum for discussion of changes in regulatory policy, the industry, or enabling technology.
To maximize the relevance of the center's research and educational programs, the faculty, fellows, and staff of the center become directly involved in finding solutions to real-world problems and challenges faced by practicing drug development scientists. These Technical Assistance Program (TAP) projects provide a practical "laboratory" for critical evaluation of the center's innovative methods and techniques.
Specifically, with the guidance and involvement of its Science Board, center scientists will collaborate with academic and industry scientists worldwide, investigating a variety of research methodologies that are directly relevant to improving the clinical evaluation of drugs in development. The educational objectives of the center will be realized through center-sponsored courses, conferences, workshops, and fellowship training. The technical assistance program of the center will provide mechanisms for the application and evaluation of new or proven scientific and science management methodologies for meeting challenges facing individual drug developers.
The center's research agenda will be influenced by the Science Board. Members of the Board are academic, government, and pharmaceutical industry scientists who have the special qualifications and desire to advance clinical drug development science. An International Advisory Board may also be formed to enable international perspective to be brought to the attention of the center.
Initially, the center will accomplish its mission with a core staff, in collaboration with a worldwide network of associated scientists, including the members of the Science Board. As the center's programs grow in both demand and financial support, additional research, educational, and administrative staff will be recruited.
The center enjoys the rich intellectual environment of the University of California, San Francisco and the School of Pharmacy and the Medical Center. In particular, the Departments of Biopharmaceutical Science and Clinical Pharmacology provide a breadth of expertise in various disciplines of basic and clinical research. The center's director and the members of the Science Board have broad experience in pharmacometrics, clinical pharmacology, biopharmaceutics, drug development, and regulatory science.
Members of the Science Board represent the core of a worldwide network of collaborating academic centers. Scientific staffs in these centers will contribute to the research, educational, and service functions of Georgetown's Center for Drug Development Science.
Improving Drug Development Using Patient Adherence Data
in Clinical Trials, May 6-7, 2008.
Brochure (PDF)
Registration site
Advanced NONMEM workshop – March 17–19, 2008 at Mission Bay Conference Center, San Francisco, CA.
More information >
UCSF-CDDS to launch The American Course on Drug Development and
Regulatory Science- September 2007
More information >
CDDS – Pharmacometric Services is available to drug researchers
More >
Howard Lee, MD, PhD, named Director of CDDS
More >
Lewis B. Sheiner Memorial. Symposium held at CDDS in December 2006
More >
This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.